Skip to main content

C44.1922 vs C44.1992

C44.1922 (Other specified malignant neoplasm of skin of right lower eyelid, including canthus) compared with C44.1992 (Other specified malignant neoplasm of skin of left lower eyelid, including canthus), from the official CMS tabular data. C44.1922 and C44.1992 code the same condition on opposite sides. MedCoder-derived

Relationship

Review

Laterality relationship

C44.1922
Right
Other specified malignant neoplasm of skin of right lower eyelid, including canthus
C44.1992
Left
Other specified malignant neoplasm of skin of left lower eyelid, including canthus

Same condition; these differ only in which side is documented.

These codes share a category and title and differ only in the side affected. The documentation decides which applies, and a bilateral code is reported only where the code set provides one.

Source: ICD-10-CM tabular list (laterality variant derived from the code title)

Can these codes be reported together?

Same condition, opposite side. C44.1922 and C44.1992 name the same condition on opposite sides of the body.

Same category and title, differing only in which side is affected — the documentation decides which one applies, and a bilateral code is reported only where the code set provides one.

Side by side

C44.1922Other specified malignant neoplasm of skin of right lower eyelid, including canthusC44.1992Other specified malignant neoplasm of skin of left lower eyelid, including canthus
Billing statusBillableBillable
ClassificationC00-D49 — NeoplasmsC00-D49 — Neoplasms
DefinitionOther specified malignant neoplasm of skin of right lower eyelid, including canthus is a billable ICD-10-CM diagnosis code (C44.1922).Other specified malignant neoplasm of skin of left lower eyelid, including canthus is a billable ICD-10-CM diagnosis code (C44.1992).
Includes
malignant neoplasm of sebaceous glands
malignant neoplasm of sweat glands
malignant neoplasm of sebaceous glands
malignant neoplasm of sweat glands

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources